The Efficacy of Sequential RT After Triple Therapy for uHCC

NCT07052448 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: sequential radiotherapy after the combination of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies

Sponsor

Fujian Provincial Hospital